{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "18164123", "DateCompleted": {"Year": "2011", "Month": "07", "Day": "19"}, "DateRevised": {"Year": "2018", "Month": "08", "Day": "15"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1016/j.canlet.2007.11.024"], "ArticleDate": [{"Year": "2007", "Month": "12", "Day": "27"}], "Journal": {"ISSN": "1872-7980", "JournalIssue": {"Volume": "262", "Issue": "1", "PubDate": {"Year": "2008", "Month": "Apr", "Day": "08"}}, "Title": "Cancer letters", "ISOAbbreviation": "Cancer Lett"}, "ArticleTitle": "1-Bromopropane induces macrophage activation via extracellular signal-regulated kinase 1/2 MAPK and NF-\u03baB pathways.", "Pagination": {"StartPage": "28", "EndPage": "36", "MedlinePgn": "28-36"}, "Abstract": {"AbstractText": ["1-Bromopropane (1-BP) has been used in the workplace as an alternative to ozone-depleting solvents. This study examined the effects of 1-BP on the production of nitric oxide (NO) and on proinflammatory cytokines, and analyzed the mechanisms involved in macrophages. 1-BP dose-dependently induced the production of NO and proinflammatory cytokines, such as IL-1\u03b2, IL-6, and TNF-\u03b1, and expression levels of these genes also increased in a dose-dependent manner. The NF-\u03baB sites were identified in the promoter of the iNOS and proinflammatory cytokine genes. Transient transfection and electrophoretic mobility shift assays revealed that NF-\u03baB-mediated the 1-BP-induced increase in the iNOS and proinflammatory cytokine expression levels. Pretreating the macrophages with the NF-\u03baB inhibitor, BAY 11-7082, and the ERK inhibitor, PD98059, inhibited NO production and iNOS expression induced by 1-BP. This demonstrates that 1-BP stimulates macrophage activation via NF-\u03baB transactivation and ERK1/2 MAP kinase phosphorylation. These results suggest that 1-BP has the potential to be inflammatory and that it has previously unrecognized immunomodulating activity."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "BK21 Project Team, Department of Pharmacy, College of Pharmacy and Research Center for Proteineous Materials, Chosun University, Seosuk-dong, Gwangju, Republic of Korea."}], "Identifier": [], "LastName": "Han", "ForeName": "Eun Hee", "Initials": "EH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hwang", "ForeName": "Yong Pil", "Initials": "YP"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lee", "ForeName": "Kyung Jin", "Initials": "KJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jeong", "ForeName": "Tae Cheon", "Initials": "TC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jeong", "ForeName": "Hye Gwang", "Initials": "HG"}], "GrantList": [{"GrantID": "06132KNTP389", "Agency": "PHS HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "Cancer Lett", "NlmUniqueID": "7600053", "ISSNLinking": "0304-3835"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "3-(4-methylphenylsulfonyl)-2-propenenitrile"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Hydrocarbons, Brominated"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-6"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Nitriles"}, {"RegistryNumber": "0", "NameOfSubstance": "Sulfones"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase Type II"}, {"RegistryNumber": "EC 2.7.11.24", "NameOfSubstance": "Extracellular Signal-Regulated MAP Kinases"}, {"RegistryNumber": "EC 2.7.11.24", "NameOfSubstance": "Mitogen-Activated Protein Kinase 3"}, {"RegistryNumber": "SJE1IO5E3I", "NameOfSubstance": "2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one"}, {"RegistryNumber": "Y9746DNE68", "NameOfSubstance": "1-bromopropane"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Extracellular Signal-Regulated MAP Kinases"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Flavonoids"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Hydrocarbons, Brominated"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-6"}, {"QualifierName": ["drug effects"], "DescriptorName": "Macrophage Activation"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["metabolism"], "DescriptorName": "Mitogen-Activated Protein Kinase 3"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide Synthase Type II"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Nitriles"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Sulfones"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tumor Necrosis Factor-alpha"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2007", "Month": "6", "Day": "29"}, {"Year": "2007", "Month": "11", "Day": "20"}, {"Year": "2007", "Month": "11", "Day": "20"}, {"Year": "2008", "Month": "1", "Day": "1", "Hour": "9", "Minute": "0"}, {"Year": "2011", "Month": "7", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2008", "Month": "1", "Day": "1", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["18164123", "10.1016/j.canlet.2007.11.024", "S0304-3835(07)00575-7"]}}], "PubmedBookArticle": []}